Top Celgene cancer drugs now 20% more expensive after latest price hikes By: MarketWatch October 23, 2017 at 13:15 PM EDT These are “the highest we have seen for these drugs,” one Wall Street analyst said. Read More >> Related Stocks: Celgene Corp Standard & Poors 500